{
    "title": "Viatris beats second-quarter revenue estimates, says divestiture plans on track",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-12380939/Viatris-beats-second-quarter-revenue-estimates-says-divestiture-plans-track.html",
    "date": "2023-08-07",
    "keywords": [
        "revenue",
        "drug",
        "treatment",
        "beat",
        "secondquarter",
        "portfolio",
        "quarter",
        "health",
        "company",
        "viatris",
        "street",
        "monday",
        "strength",
        "premarket",
        "trading",
        "drugmaker",
        "divestiture",
        "consumer",
        "europe",
        "divestment",
        "noncore",
        "move",
        "focus",
        "core",
        "ophthalmology",
        "dermatology",
        "part",
        "strategy",
        "demand",
        "cancer",
        "lenalidomide",
        "track",
        "product",
        "fullrevenue",
        "forecast",
        "range",
        "profit",
        "merger",
        "mylan",
        "pfizer",
        "business",
        "arthritis",
        "celebrex",
        "dysfunction",
        "viagra",
        "epilepsy",
        "lyrica",
        "zoloft",
        "partner",
        "ltd",
        "food",
        "administration",
        "application",
        "injection",
        "sclerosis",
        "regulator",
        "decision",
        "march",
        "reporting",
        "roy",
        "bengaluru",
        "editing",
        "shweta",
        "agarwal"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}